Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Divyasha Saxena

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Vaccine|November 22, 2018
Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigenAndrew G Diamos, Dalia Larios, Lauren Brown, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 22, 2011
Molecular detection and characterization of West Nile virus associated with multifocal retinitis in patients from southern IndiaJyoti Shukla, Divyasha Saxena, Sivakumar Rathinam, et al.
Plos Pathogens|November 26, 2024
Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidateGang Ye, Fan Bu, Divyasha Saxena, et al.
Plos Pathogens|May 18, 2026
Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escapeFan Bu, Divyasha Saxena, Hailey Turner-Hubbard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2026
Exosome-mediated antiviral testing system and identification of Punicalagins and Anthocyanidins as promising antiviral agents against SARS-CoV-2Raghuram Kandimalla, Farrukh Aqil, Divyasha Saxena, et al.
Vaccines|June 27, 2025
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville CohortLalit Batra, Divyasha Saxena, Triparna Poddar, et al.
The Journal of Clinical Investigation|January 8, 2025
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infectionJian Zheng, Hima Dhakal, Enya Qing, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2026
A SARS-CoV-2 entry inhibitor trimerizes to lock the spike protein in a closed conformationHuihui Mou, Bo Gao, Gang Ye, et al.
Science Advances|January 20, 2022
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesLong Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Vaccine|November 22, 2018
Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigenAndrew G Diamos, Dalia Larios, Lauren Brown, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 22, 2011
Molecular detection and characterization of West Nile virus associated with multifocal retinitis in patients from southern IndiaJyoti Shukla, Divyasha Saxena, Sivakumar Rathinam, et al.
Plos Pathogens|November 26, 2024
Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidateGang Ye, Fan Bu, Divyasha Saxena, et al.
Plos Pathogens|May 18, 2026
Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escapeFan Bu, Divyasha Saxena, Hailey Turner-Hubbard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2026
Exosome-mediated antiviral testing system and identification of Punicalagins and Anthocyanidins as promising antiviral agents against SARS-CoV-2Raghuram Kandimalla, Farrukh Aqil, Divyasha Saxena, et al.
Vaccines|June 27, 2025
Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville CohortLalit Batra, Divyasha Saxena, Triparna Poddar, et al.
The Journal of Clinical Investigation|January 8, 2025
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infectionJian Zheng, Hima Dhakal, Enya Qing, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2026
A SARS-CoV-2 entry inhibitor trimerizes to lock the spike protein in a closed conformationHuihui Mou, Bo Gao, Gang Ye, et al.
Science Advances|January 20, 2022
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesLong Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Pageof 2